EyePoint (EYPT) Current Deferred Revenue (2011 - 2025)
EyePoint's Current Deferred Revenue was $5.12 million in Q1 2025, down 86.7% from $38.38 million a year earlier and down 71.2% from the prior quarter.
Powered by 
Analysis
EyePoint (EYPT) Current Deferred Revenue (2011 - 2025) Analysis & Trends
At the end of FY2024, Current Deferred Revenue at EyePoint came in at $17.78 million, down 53.9% from FY2023.
- Current Deferred Revenue shows a five-year compound annual growth rate of 311.9% (FY2019 to FY2024).
- In earlier years, Current Deferred Revenue was $38.59 million in FY2023, $1.21 million in FY2022 (+12.7%), $1.07 million in FY2021 (+13.1%) and $945,000 in FY2020.
- The Q1 2025 figure marks the lowest quarterly Current Deferred Revenue since Q1 2023.
- Compared with a year earlier, Current Deferred Revenue has declined for four straight quarters, with an average decline of 49.0% over the last four quarters.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q3 2021 (growth of 245.0%); the worst was Q1 2025 (a decline of 86.7%).
- Per Business Quant data, EYPT's Current Deferred Revenue in the three quarters before Q1 2025 was $17.78 million (Q4 2024), $26 million (Q3 2024) and $33.34 million (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | EyePoint | 277.89 Mn | -635.23 Mn | 507,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | 17.78 Mn |
| Sep 30, 2024 | 26.00 Mn |
| Jun 30, 2024 | 33.34 Mn |
| Mar 31, 2024 | 38.38 Mn |
| Dec 31, 2023 | 38.59 Mn |
| Sep 30, 2023 | 39.84 Mn |
| Jun 30, 2023 | 42.08 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 1.01 Mn |
| Mar 31, 2021 | 973,000.00 |
| Dec 31, 2020 | 945,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Mar 31, 2020 | 30,000.00 |
API Access
EyePoint Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=EYPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "EYPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=EYPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();